SUNE BIOP |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1175 USD | -1.26% |
|
+0.34% | +657.96% |
| Apr. 19 | Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product | MT |
| Apr. 19 | Top Premarket Decliners | MT |
Chart calendar SUNE BIOP
461ed8adde687d1b6ac2cbef44.OdGGHiOhRFq5hOZ9-uj_pHcywupS4vHSWCRffzi9b7Q.D6X1dlroLTeJ65Ioo9667CFUqY9rr7m3DnIINkjPG9pzkOMqE-03Ld3DjQ~3746eb2a1ed100a8000c81b8563529be
Upcoming events on SUNE BIOP
Past events on SUNE BIOP
| 2024-04-01 03:47 pm | Q4 2023 Earnings Release |
| 2023-12-07 10:00 am | Annual General Meeting |
| 2023-11-13 08:30 am | Q3 2023 Earnings Release |
| 2023-10-12 10:00 am | Special Meeting of Warrant Holders |
| 2023-08-14 02:24 pm | Q2 2023 Earnings Release |
| 2023-05-10 06:28 pm | Q1 2023 Earnings Release |
| 2023-04-05 08:00 am | Q4 2022 Earnings Release |
| 2022-11-07 02:48 pm | Q3 2022 Earnings Release |
| 2022-08-03 05:24 pm | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 24,1 22,5 7.02% | 44,4 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -4,79 -4,80 0.36% | -0,24 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -4,11 -4,00 -2.89% | 0,84 |
|
Net income Million USD | Released Forecast Spread | -26,7 | -4,51 -4,21 -7.02% | 0,68 |
|
EPS USD | Released Forecast Spread | -176 | -19,0 -16,0 -18.75% | 0,84 |
| Announcement Date | 04/04/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,56 5,00 11.22% | 5,96 6,00 -0.71% | 7,68 6,10 25.9% | 7,00 | 9,00 | 12,6 | 15,8 |
|
EBIT Million USD | Released Forecast Spread | -0,99 -2,14 53.68% | -0,78 -2,05 62.01% | -1,19 -1,20 1.42% | -1,29 | -0,61 | 0,30 | 1,37 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,81 -1,87 56.37% | -0,61 -1,73 64.75% | -1,03 -0,91 -12.63% | -1,01 | -0,34 | 0,57 | 1,63 |
|
Net income Million USD | Released Forecast Spread | -0,90 -1,87 51.67% | -0,65 -1,75 62.81% | -1,25 -0,95 -30.99% | -1,05 | -0,38 | 0,53 | 1,59 |
|
EPS USD | Released Forecast Spread | -2,00 -8,00 75% | -4,00 -6,00 33.33% | -5,70 -3,00 -90% | -1,04 | -0,37 | 0,55 | 1,60 |
| Announcement Date | 10/08/23 | 13/11/23 | 28/03/24 | - | - | - | - |
| Today 06:25 am | ELI LILLY AND COMPANY: Q1 2024 Earnings Release |
| 2024-04-30 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 02:00 am | GSK PLC: Q1 2024 Earnings Release |
| 2024-05-01 03:00 am | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 2024-05-01 06:45 am | PFIZER, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-01 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
Past sector events for SUNE BIOP
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SBFM Stock
- SBFM Stock
- Calendar SUNE BIOP
